Surmodics Inc (SRDX): שווי שוק להכנסות

Surmodics, Inc. (SRDX) ensures a stable output of sterile catheters through its own manufacturing facilities in the US and Ireland. This price-to-sales chart from the GURU.Markets terminal shows the value has stabilized at 5.10. Revenues are based on licensing royalties for unique coatings. Strong pricing power and patents for chemical compositions minimize the risks of component substitution in partners' products.
פילוחים אנליטיים של חברת Surmodics Corp (SRDX)

The P/S ratio compares the market capitalization of Surmodics, Inc. (SRDX) to its annual revenue, determining the value of each dollar of sales in the eyes of investors. Analyzing the P/S multiple can reveal asset overvaluation, particularly when the efficiency of chemical production outsourcing and cloud logistics fails to provide a proportional acceleration in the company's revenue growth rates.